Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suning Chen

Showing results (231-240 of 368) with videos related to

Pageof 37
Sort By:
Acta Haematologica|May 16, 2019
An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3Yang Cao, Li Yao, Yue Liu, et al.
Annals of Hematology|February 3, 2023
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemiaYingxin Sun, Qinrong Wang, Xingxia Zhang, et al.
Blood Cancer Journal|October 11, 2023
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemiaKeyuan Zhang, Xiang Zhang, Yang Xu, et al.
Nature Communications|January 13, 2025
CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemiaTianhui Liu, Tanzhen Wang, Lijuan Qi, et al.
Oxidative Medicine and Cellular Longevity|February 10, 2022
Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute ErythroleukemiaWenjie Liu, Zijuan Wu, Yan Yu, et al.
Hematology (Amsterdam, Netherlands)|February 25, 2021
Safety and efficacy of different doses of anthracyclines combined with arsenic trioxide and all-trans retinoic acid in the treatment of de novo acute promyelocytic leukemiaYaxue Wu, Peng Ke, Haixia Zhou, et al.
Frontiers in Immunology|May 13, 2022
The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell TransplantationMeng Shan, Danya Shen, Tiemei Song, et al.
Blood Cancer Journal|August 23, 2024
Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual diseaseJialing Lu, Xiebing Bao, Jihao Zhou, et al.
Hematology (Amsterdam, Netherlands)|September 23, 2021
A comparative study of porcine antihuman lymphocyte globulin versus antithymocyte globulin-fresenius in an allogeneic hematopoietic cell transplantation conditioning regimen for severe aplastic anemiaYanming Zhang, Limin Liu, Yejun Si, et al.
Acta Haematologica|November 9, 2016
Prevalence of Monoclonal Gammopathy of Undetermined Significance in an Apparently Healthy Yixing Population in Mainland ChinaJiao Li, Lijun Wen, Junming Tang, et al.
Pageof 37

Showing results (231-240 of 368) with videos related to

Sort By:
Pageof 37
Acta Haematologica|May 16, 2019
An Atypical PML-RARA Rearrangement Resulting from Submicroscopic Insertion of the RARA Gene at the PML Locus with Novel Breakpoints within PML Exon 7b and RARA Exon 3Yang Cao, Li Yao, Yue Liu, et al.
Annals of Hematology|February 3, 2023
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemiaYingxin Sun, Qinrong Wang, Xingxia Zhang, et al.
Blood Cancer Journal|October 11, 2023
Efficacy of venetoclax combined with hypomethylating agents in young, and unfit patients with newly diagnosed core binding factor acute myeloid leukemiaKeyuan Zhang, Xiang Zhang, Yang Xu, et al.
Nature Communications|January 13, 2025
CPSF6-RARγ interacts with histone deacetylase 3 to promote myeloid transformation in RARG-fusion acute myeloid leukemiaTianhui Liu, Tanzhen Wang, Lijuan Qi, et al.
Oxidative Medicine and Cellular Longevity|February 10, 2022
Functional Evaluation of KEL as an Oncogenic Gene in the Progression of Acute ErythroleukemiaWenjie Liu, Zijuan Wu, Yan Yu, et al.
Hematology (Amsterdam, Netherlands)|February 25, 2021
Safety and efficacy of different doses of anthracyclines combined with arsenic trioxide and all-trans retinoic acid in the treatment of de novo acute promyelocytic leukemiaYaxue Wu, Peng Ke, Haixia Zhou, et al.
Frontiers in Immunology|May 13, 2022
The Clinical Value of Procalcitonin in the Neutropenic Period After Allogeneic Hematopoietic Stem Cell TransplantationMeng Shan, Danya Shen, Tiemei Song, et al.
Blood Cancer Journal|August 23, 2024
Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual diseaseJialing Lu, Xiebing Bao, Jihao Zhou, et al.
Hematology (Amsterdam, Netherlands)|September 23, 2021
A comparative study of porcine antihuman lymphocyte globulin versus antithymocyte globulin-fresenius in an allogeneic hematopoietic cell transplantation conditioning regimen for severe aplastic anemiaYanming Zhang, Limin Liu, Yejun Si, et al.
Acta Haematologica|November 9, 2016
Prevalence of Monoclonal Gammopathy of Undetermined Significance in an Apparently Healthy Yixing Population in Mainland ChinaJiao Li, Lijun Wen, Junming Tang, et al.
Pageof 37